Mersana Therapeutics Inc (MRSN) — Strategic Asset Allocation Index
Mersana Therapeutics Inc (MRSN) has a Strategic Asset Allocation Index of 14.9% as of June 2023. Strategic assets (PP&E of $13.40 Million plus long-term investments of $-) total $13.40 Million, measured against net assets of $89.80 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Mersana Therapeutics Inc Strategic Asset Allocation Index (2017–2022)
This chart shows how Mersana Therapeutics Inc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 14.9%, representing strategic assets of $13.40 Million against net assets of $89.80 Million USD. Explore MRSN cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Mersana Therapeutics Inc (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Mersana Therapeutics Inc from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Mersana Therapeutics Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 15.7% | $14.46 Million | $14.46 Million | $- | $92.06 Million | ▲ +3.5 pp |
| 2021 | 12.2% | $14.86 Million | $14.86 Million | $- | $121.74 Million | ▲ +11.4 pp |
| 2020 | 0.8% | $1.73 Million | $1.73 Million | $- | $228.09 Million | ▼ -5.3 pp |
| 2019 | 6.1% | $4.76 Million | $4.76 Million | $- | $78.32 Million | ▼ -24.6 pp |
| 2018 | 30.6% | $2.69 Million | $2.69 Million | $0.00 | $8.79 Million | ▲ +12.3 pp |
| 2017 | 18.3% | $12.80 Million | $2.32 Million | $10.48 Million | $69.99 Million | — |